|
Aug 1
|
Iovance Biotherapeutics (IOVA): Promising TIL Therapy Gains Momentum Amid Funding Challenges
|
|
Jul 31
|
Iovance Biotherapeutics (IOVA) Names Corleen Roche as New CFO
|
|
Jul 30
|
Is Iovance Biotherapeutics Stock Due for a Big Rally?
|
|
Jul 29
|
This Beaten-Down Healthcare Stock Could Jump 720%, According to a Wall Street Analyst. Is It Time to Buy?
|
|
Jul 24
|
Iovance Biotherapeutics to Host Second Quarter and First Half 2025 Financial Results and Corporate Updates Webcast on Thursday, August 7, 2025
|
|
Jul 23
|
BC-Most Active Stocks
|
|
Jul 21
|
This Healthcare Stock Just Hit a 52-Week Low -- but Wall Street Sees 380% Upside
|
|
Jun 20
|
Gene Therapy Stocks Fall Amid More Turmoil at FDA
|
|
Feb 10
|
Iovance Biotherapeutics Appoints Dan Kirby as Chief Commercial Officer
|
|
Jan 3
|
Exploring 3 High Growth Tech Stocks In The United States
|
|
Jan 3
|
Why Iovance Biotherapeutics Stock Zoomed More Than 5% Higher Today
|
|
Jan 2
|
Why Iovance Biotherapeutics Inc. (IOVA) Is Skyrocketing
|
|
Oct 12
|
Is Iovance Biotherapeutics, Inc. (IOVA) the Best Growth Stock Under $10 to Buy?
|
|
Oct 10
|
Is Iovance Biotherapeutics, Inc. (IOVA) the Best Stock Under $10 With High Potential?
|
|
Oct 9
|
Strong Investor Sentiment: Artisan Partners Highlights Iovance Biotherapeutics, Inc. (IOVA)
|
|
Aug 27
|
Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?
|
|
Aug 26
|
High Growth Tech Stocks To Watch In August 2024
|
|
Jul 29
|
Why Iovance Biotherapeutics Stock Stumbled Today
|
|
Jul 29
|
Iovance Biotherapeutics to Host Second Quarter and First Half 2024 Financial Results Conference Call and Webcast on Thursday, August 8, 2024
|
|
Jul 29
|
Here’s Why Iovance Biotherapeutics (IOVA) Declined in Q2
|